🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Half of children taking 'miracle' cystic fibrosis drugs may be struck by severe mood changes, study reveals | Daily Mail Online dailymail.co.uk/health/article…

CF patients eat high-fat diet despite guidelines: Review cysticfibrosisnewstoday.com/news/cf-patien…

Trikafta revolutionized treatment for Cystic Fibrosis, reaching >90% of patients variants. But what about the remaining untreatable 10%? We studied several poorly responsive, FDA-unapproved variants and paved a path forward for drug development. biorxiv.org/content/10.110… 1/7

UK #CysticFibrosis community! Tell us about your thoughts on inhaled meds & interacting with your care providers post-Kaftrio in this anonymous 5-10 min research survey. Your voice matters! Please share! [shef.qualtrics.com/jfe/form/SV_6V…] #CF

NICE approves three cystic fibrosis drugs for NHS use - The Pharmaceutical Journal pharmaceutical-journal.com/article/news/n…

Boy, 3, has combination of CFTR mutations, no CF symptoms: Report cysticfibrosisnewstoday.com/news/boy-3-com…

NICE Board says new method allowing greater weight to be given to severe diseases is working | NICE nice.org.uk/news/articles/…

GRAMPUS-CF aims to understand gut symptoms in people with cystic fibrosis (CF) so that we can develop treatments. If you are a person with CF, you can help! Visit our website for participant information, online consent and to download the app. grampus-cf.org Thank you!

#NewProfilePic

investors.vrtx.com/news-releases/…

🚨 New in The Lancet Respiratory Medicine Phase 3 data on vanzacaftor–tezacaftor–deutivacaftor in #cysticfibrosis Read open access here: Patients aged 6–11 years tinyurl.com/446ju86t Patients aged 12 years and older tinyurl.com/5y453b56

Body composition changes and clinical outcomes in pediatric cystic fibrosis during 24 months of lumacaftor ivacaftor therapy based on real-world data | Scientific Reports nature.com/articles/s4159…

Do intravenous antibiotics improve pulmonary exacerbations (flare-ups) in people with cystic fibrosis? | Cochrane cochrane.org/CD009730/CENTR…

Cystic Fibrosis and Bone Health | Nature Research Intelligence nature.com/research-intel…

Cystic Fibrosis and Fungal Infections | Nature Research Intelligence nature.com/research-intel…

Mycobacterium Abscessus Infections and Cystic Fibrosis | Nature Research Intelligence nature.com/research-intel…

Today the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label expansion of our fourth cystic fibrosis (CF) medicine to include an expanded population with certain mutations. This marks an important step

investors.vrtx.com/news-releases/…

Today the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for our fifth cystic fibrosis (CF) medicine. This is an important step towards our goal of treating all people living with CF.

$VRTX on pace to lose $15B in market value today.